Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Celularity Inc 170 PARK AVE FLORHAM PARK NJ 07932 USA

www.celularity.com P: 908-768-2170

Description:

Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells targeting indications across cancer, infectious and degenerative diseases. Celularity Inc., formerly known as GX Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 59,684
Enterprise Value, $K 83,314
Shares Outstanding, K 19,378
Annual Sales, $ 17,980 K
Annual Net Income, $ 14,190 K
Last Quarter Sales, $ 3,790 K
Last Quarter Net Income, $ -93,880 K
EBIT, $ 37,830 K
EBITDA, $ 50,880 K
60-Month Beta 0.43
% of Insider Shareholders 20.70%
% of Institutional Shareholders 19.02%
Float, K 15,367
% Float 79.30%
Short Volume Ratio 0.82

Growth:

1-Year Return -40.75%
3-Year Return -97.03%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.60 on 01/02/24
Latest Earnings Date 05/27/24
Earnings Per Share ttm 0.60
EPS Growth vs. Prev Qtr -117.65%
EPS Growth vs. Prev Year -300.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 02/29/24

CELU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 78.92%
Debt/Equity 1.16
Price/Sales 3.58
Price/Cash Flow 1.71
Price/Book 2.00
Book Value/Share 1.56
Interest Coverage 0.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar